Back to Search Start Over

Ventilator-associated Pneumonia caused by commensal oropharyngeal Flora; [corrected] a retrospective Analysis of a prospectively collected Database

Authors :
Helke A. van Dessel
Paul Roekaerts
Dennis C J J Bergmans
Walther N.K.A. van Mook
Johan I. M. van der Velde
Paul H. M. Savelkoul
Johannes B. J. Scholte
Catharina F. M. Linssen
Med Microbiol, Infect Dis & Infect Prev
Anesthesiologie
RS: NUTRIM - R3 - Chronic inflammatory disease and wasting
RS: CAPHRI School for Public Health and Primary Care
RS: CAPHRI - R4 - Health Inequities and Societal Participation
Source :
BMC Pulmonary Medicine, BMC Pulmonary Medicine, 15:86. BioMed Central Ltd
Publication Year :
2015

Abstract

BACKGROUND: The significance of commensal oropharyngeal flora (COF) as a potential cause of ventilator-associated pneumonia (VAP) is scarcely investigated and consequently unknown. Therefore, the aim of this study was to explore whether COF may cause VAP. METHODS: Retrospective clinical, microbiological and radiographic analysis of all prospectively collected suspected VAP cases in which bronchoalveolar lavage fluid exclusively yielded >/= 10(4) cfu/ml COF during a 9.5-year period. Characteristics of 899 recent intensive care unit (ICU) admissions were used as a reference population. RESULTS: Out of the prospectively collected database containing 159 VAP cases, 23 patients were included. In these patients, VAP developed after a median of 8 days of mechanical ventilation. The patients faced a prolonged total ICU length of stay (35 days [P < .001]), hospital length of stay (45 days [P = .001]), and a trend to higher mortality (39 % vs. 26 %, [P = .158]; standardized mortality ratio 1.26 vs. 0.77, [P = .137]) compared to the reference population. After clinical, microbiological and radiographic analysis, COF was the most likely cause of respiratory deterioration in 15 patients (9.4 % of all VAP cases) and a possible cause in 2 patients. CONCLUSION: Commensal oropharyngeal flora appears to be a potential cause of VAP in limited numbers of ICU patients as is probably associated with an increased length of stay in both ICU and hospital. As COF-VAP develops late in the course of ICU admission, it is possibly associated with the immunocompromised status of ICU patients.

Details

ISSN :
14712466
Volume :
15
Database :
OpenAIRE
Journal :
BMC pulmonary medicine
Accession number :
edsair.doi.dedup.....fae2799858d5e40726b769df24f2fd51